Neoplasms, Squamous Cell

14 clinical trials · Condition

Record	Firm	Date
Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients (NCT05252078)	Jiangxi Provincial Cancer Hospital	2022-06-02
Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions (NCT03937791)	National Cancer Institute (NCI)	2019-10-09
Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma (NCT04124198)	Christian von Buchwald	2019-03-01
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors (NCT03685591)	Pfizer	2018-10-04
Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients (NCT02526953)	Blokhin's Russian Cancer Research Center	2016-01-01
Safety Study of SEA-CD40 in Cancer Patients (NCT02376699)	Seagen Inc.	2015-02-28
Intended Use Study of the BD SurePath Plus™ Pap (NCT01234480)	Becton, Dickinson and Company	2010-09-01
A Post-marketing Surveillance Study on Erbitux in Combination With Platinum-based Chemotherapy in Metastatic/Recurrent Squamous Cell Cancer of the Head and Neck (NCT01075841)	Merck KGaA, Darmstadt, Germany	2009-03-01
Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV (NCT01709448)	National Institute of Allergy and Infectious Diseases (NIAID)	2009-01-01
Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer (NCT00272181)	Sesen Bio, Inc.	2006-01-01
Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer (NCT00412776)	Sesen Bio, Inc.	2005-12-01
IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma (NCT00229723)	AstraZeneca	2004-11-01

Track Neoplasms, Squamous Cell automatically

Every clearance here is in the API, with alerts when new ones post.